Bharat Immunologicals P/E Ratio
Bharat Immunologicals P/E ratio. Bharat Immunologicals (BIBCL) P/E ratio is not applicable — EPS (TTM) ₹-3.95. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-3.95
Healthcare Peers with Valid P/E Ratios — BIBCL Comparison
Healthcare sector average P/E 55.62, median 31.7 — BIBCL excluded (negative EPS).
Sector Average PE
55.62
Sector Median PE
31.7
Lowest PE
2.07
Profitable Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.07 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.28 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.78 | ₹65 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹46 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see BIBCL share price screener.
- Check BIBCL company valuation to track the company's total market size over time.
- Also explore BIBCL price trends to track price trends across different timeframes.